June 17, 2024   USA
The Sugar Science: Ask the Expert
Diamyd Medical’s CEO Ulf Hannelius discusses Decoding the Future: Leveraging Biomarkers in Antigen-Specific Immunotherapy for Type 1 Diabetes.

The Sugar Science is an interactive digital platform founded to curate the scientific conversation among type 1 diabetes (T1D) researchers.
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.

Order GAD for preclinical research